Pharmacological inhibition from the ataxia telangiectasia and Rad3-associated protein serine/threonine kinase (ATR; also called FRAP-related protein (FRP1)) has emerged to be a promising technique for cancer therapy that exploits artificial lethal interactions with proteins linked to DNA hurt fix, overcomes resistance to other therapies and boosts antitumour immunity. Several novel, https://anthonyk666whs8.muzwiki.com/user